{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib7japfoeymwic4sjsk2lxfy6ejcuojm4kyx4mqb5y5qn3k4rbedy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mf5awjpnipj2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicawrklm2fn2hrga6ijgd6zgevr32h3xaitqxjqo77zgbkqjzfkxe"
    },
    "mimeType": "image/jpeg",
    "size": 80988
  },
  "path": "/2026/02/18/moderna-fda-reversal-vinay-prasad/?utm_campaign=rss",
  "publishedAt": "2026-02-18T14:00:45.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Matt's Take",
    "biotechnology",
    "FDA",
    "Moderna",
    "Pharmaceuticals",
    "STAT+",
    "Vaccines"
  ],
  "textContent": "For drugmakers and vaccine developers, an FDA reversal on Moderna's flu vaccine is better than the alternative. But it is also another sign of agency chaos.",
  "title": "STAT+: The FDA’s Moderna pirouette is one more sign of chaos at the agency",
  "updatedAt": "2026-02-18T14:00:49.000Z"
}